Physician profile
Walter P Samora
NPI 1194936120
$128,310.70
in general payments reported to CMS, 2019-2025
17 companies · $9,541 in 2025
The $9,541 reported for 2025 was more than what 91% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $15K · 2021: $19K · 2022: $12K · 2023: $17K · 2024: $19K · 2025: $9,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $27K · Consulting Fee: $8,778 · Travel and Lodging: $5,244 · Food and Beverage: $4,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $26,515.62 |
| Consulting Fee | $8,777.77 |
| Travel and Lodging | $5,243.98 |
| Food and Beverage | $4,185.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $72,420.12 | 2019-2025 | Creo 5.5, Creo |
| Medical Device Business Services, INC. | $43,296.00 | 2019-2024 | Expedium Verse |
| Alphatec Spine, INC | $7,584.63 | 2022-2025 | Other - Miscellaneous, Invictus Open, Solus Alif |
| Depuy Synthes Sales INC. | $2,277.13 | 2020-2025 | Unium, Na, Lcp |
| Orthofix Medical, INC. | $651.77 | 2019-2024 | Spinal-Stim |
| Nuvasive, INC. | $587.87 | 2021-2022 | |
| Arteriocyte Medical Systems, INC. | $290.76 | 2025 | Magellan |
| Prosidyan, INC | $186.00 | 2021 | |
| Orthopediatrics Corp. | $185.54 | 2024-2025 | |
| Si-Bone, INC. | $157.37 | 2023 | |
| Degen Medical, INC. | $133.37 | 2022 | |
| Smith+Nephew, INC. | $127.42 | 2019 | |
| Avanos Medical | $126.12 | 2022 | |
| Heron Therapeutics, INC. | $121.74 | 2023 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $114.03 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $29.46 | 2020 | |
| Vericel Corporation | $21.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Samora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.